Regulator

Summary of regulator annotations and link-out to annotation databases

Basic gene annotations are collected from Uniprot and displayed with links to original sources. A quick link to explore the genomic context with Uniprot Browser is available.

RELA - RELA proto-oncogene, NF-kB subunit

Function

NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The heterodimeric RELA-NFKB1 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. The NF-kappa-B heterodimeric RELA-NFKB1 and RELA-REL complexes, for instance, function as transcriptional activators. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. The inhibitory effect of I-kappa-B on NF-kappa-B through retention in the cytoplasm is exerted primarily through the interaction with RELA. RELA shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Beside its activity as a direct transcriptional activator, it is also able to modulate promoters accessibility to transcription factors and thereby indirectly regulate gene expression. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1. Essential for cytokine gene expression in T-cells (PubMed:15790681). The NF-kappa-B homodimeric RELA-RELA complex appears to be involved in invasin-mediated activation of IL-8 expression. Key transcription factor regulating the IFN response during SARS-CoV-2 infection (PubMed:33440148).

Uniprot Browser
Entrez IDEnsEMBL IDPreferred NameUniprot ID
5970 ENSG00000173039 RELA Q04206

List of causal flows containing the regulator.

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow, a mutation may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulonthat contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows with ENSG00000173039 as Regulator

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-00697HMCN1up-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-01253RNF168up-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-13852ADAMTS8down-regulatesRELAactivatesR-314932Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-15742FN1up-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-23273RNF17up-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-24547SEMA3Cdown-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX

CMF-27344CHD5up-regulatesRELAactivatesR-314931Drugs (2)

Regulator Drugs (0)

Regulon Drugs (2)

DAVANAT, CINTREDEKIN BESUDOTOX